Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 28, 2025 • 4:31 PM ET

Date/Time Source News Release
03/19/2025 07:00 AM EDT GlobeNewswire Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
03/06/2025 04:01 PM EST GlobeNewswire Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
02/19/2025 09:15 AM EST GlobeNewswire NAYA Biosciences Announces Nomination of New Board Members
11/05/2024 08:00 AM EST GlobeNewswire Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/01/2024 08:00 AM EDT GlobeNewswire Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
10/07/2024 04:01 PM EDT GlobeNewswire Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
09/23/2024 07:00 AM EDT GlobeNewswire Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations
09/22/2024 10:00 AM EDT GlobeNewswire Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC
09/14/2024 03:30 AM EDT GlobeNewswire Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024
08/08/2024 04:05 PM EDT GlobeNewswire Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
Page

Additional News

As of March 28, 2025 • 4:31 PM ET

Date/Time Source News Release
03/25/2025 12:58 AM EDT SeekingAlpha Black Diamond Therapeutics Trades Well Below Cash After Lucrative Deal With Servier
03/19/2025 01:45 PM EDT AllPennyStocks.com This Biotech Is Finding Mid-Week Success Following Licensing Agreement Announcement
03/19/2025 11:38 AM EDT InvestorBrandNetwork Black Diamond Therapeutics Inc. (NASDAQ: BDTX) Sees Notable Increase in Wednesday Morning Market Activity
03/19/2025 09:06 AM EDT 24/7 Market News Black Diamond Forges Global Pact with Servier for BDTX-4933, a Next-Gen Cancer Fighter
03/19/2025 08:57 AM EDT SeekingAlpha Black Diamond Therapeutics surges on licensing deal
03/13/2025 03:47 PM EDT SeekingAlpha Black Diamond Therapeutics: In Decline, But Why?
03/08/2025 04:31 AM EST US Earnings Reports Expected earnings - Black Diamond Therapeutics Inc.
03/06/2025 05:06 PM EST SeekingAlpha Black Diamond Therapeutics GAAP EPS of -$0.28 beats by $0.03
12/30/2024 03:07 PM EST SeekingAlpha Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts
12/11/2024 12:00 PM EST Zacks Black Diamond (BDTX) Upgraded to Buy: Here's What You Should Know
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.